![Christoph Westphal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christoph Westphal
Founder at
Longwood Fund Management LLC
Profile
Christoph H.
Westphal is the founder of Concert Pharmaceuticals, Inc. (2006), Sirtris Pharmaceuticals, Inc. (2004), Nanosys, Inc. (2001), Longwood Fund Management LLC (2010), Momenta Pharmaceuticals, Inc. (2001), Verastem, Inc. (2010), Flex Pharma, Inc. (2014), Alnara Pharmaceuticals, Inc. (2008), TScan Therapeutics, Inc. (2018), PPD Dermatology LLC (2006), Acceleron Pharma, Inc. (2003), OvaScience, Inc. (2011), and ImmuneID, Inc. (2020).
Dr. Westphal is also the founder of DEM BioPharma, Inc., Alnylam Pharmaceuticals, Inc. Current jobs include Chairman at Immunitas Therapeutics, Inc. (2019), Director at Recros Medica, Inc. (2018), Director at Solu Therapeutics, Inc., Partner at Longwood Fund LP (2010), Member-Overseers Board at Boston Symphony Orchestra, Inc., Manager at Longwood Fund II GP LLC, and Member at Commercial Club of Boston.
Former jobs include Director at Saegis Pharmaceuticals, Inc., Director at Werewolf Therapeutics, Inc., Director at Pyxis Oncology, Inc., Director at Hydra Biosciences, Inc., Principal at McKinsey & Co., Inc., Senior Advisor at Exeter Venture Management Company LLC, General Partner at Polaris Growth Management LLC (2000-2005), and President at GSK Equity Investments Ltd (2010-2011).
Education includes undergraduate degree from The Trustees of Columbia University in The City of New York, doctorate from Harvard University, and doctorate from Harvard Medical School.
Christoph Westphal active positions
| Companies | Position | Start |
|---|---|---|
Longwood Fund Management LLC
 Longwood Fund Management LLC Investment ManagersFinance Longwood Fund invests in companies located in the United States. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Founder | 2010-01-31 |
Longwood Fund II GP LLC | Corporate Officer/Principal | - |
Longwood Fund LP
 Longwood Fund LP Investment ManagersFinance Acts as Venture Capital Fund | Corporate Officer/Principal | 2009-12-31 |
Boston Symphony Orchestra, Inc.
 Boston Symphony Orchestra, Inc. Movies/EntertainmentConsumer Services Performs symphony orchestra concerts | Director/Board Member | - |
Commercial Club of Boston
 Commercial Club of Boston Miscellaneous Commercial ServicesCommercial Services Commercial Club of Boston is a company that operates in the Membership Organizations industry. It employs 50 to 99 people and has 5M to 10M of revenue. Commercial Club of Boston is based in Boston, MA. | Corporate Officer/Principal | - |
Recros Medica, Inc.
 Recros Medica, Inc. Medical SpecialtiesHealth Technology Develops medical devices for fractional skin resection | Director/Board Member | 2018-01-03 |
Immunitas Therapeutics, Inc.
 Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Chairman | 2019-12-17 |
ImmuneID, Inc.
 ImmuneID, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company | Founder | 2020-10-06 |
Solu Therapeutics
 Solu Therapeutics BiotechnologyHealth Technology Operates as a biotechnology that develops therapeutics to eliminate disease-driving cells in cancer, immunology and autoimmunity | Director/Board Member | - |
Former positions of Christoph Westphal
| Companies | Position | End |
|---|---|---|
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Training of Christoph Westphal
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
57
1st degree connections
33
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 33 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Nanosys, Inc.
 Nanosys, Inc. Chemicals: SpecialtyProcess Industries Develops and manufactures inorganic nanostructures and other related products | Process Industries |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Sirtris Pharmaceuticals, Inc.
 Sirtris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs and pharmaceuticals | Health Technology |
PPD Dermatology LLC
 PPD Dermatology LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Concert Pharmaceuticals, Inc.
 Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel medicines | Health Technology |
Alnara Pharmaceuticals, Inc.
 Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics for the treatment of metabolic diseases | Health Technology |
Longwood Fund LP
Longwood Fund LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Flex Pharma, Inc.
 Flex Pharma, Inc. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Health Technology |
Recros Medica, Inc.
Recros Medica, Inc. Medical SpecialtiesHealth Technology Develops medical devices for fractional skin resection | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Polaris Growth Management LLC
 Polaris Growth Management LLC Investment ManagersFinance Polaris Partners invests primarily in companies in the consumer technology, digital media/entertainment, e-Commerce, network hardware, software and semiconductors sectors. They invest in seed, early-stage and high growth, middle-market companies. The firm's early-stage investments focus on information technology and life sciences companies. Within the information technology sector, Polaris looks for companies that are developing Internet and broadband infrastructure, enterprise software products, e-Commerce products/services, digital media/entertainment, consumer software, network hardware and network software. In the life sciences sector, the firm looks for companies that are developing medical devices, pharmaceuticals, genomics, proteomics, drug delivery, medical services and consumer products and services. Polaris' private equity efforts focus on high-growth, middle-market companies in industries including technology, healthcare, digital media, consumer products and services and business services. Polaris serves as the lead or co-lead investor in the vast majority of their portfolio companies. The firm participates in minority growth equity investments, recapitalizations with liquidity and LBOs. | Finance |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Finance |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exeter Venture Management Company LLC
 Exeter Venture Management Company LLC Investment ManagersFinance Flybridge Capital Partners invests in companies located in the United States. The firm focuses on AI sector companies. It provides financing for pre-seed, seed and early-stage and later stage capital requirements with an investment size of USD 0.25 - 10 million. It also acts as lead or co-lead investor. | Finance |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Hydra Biosciences, Inc.
 Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular regeneration medicines to treat pain, inflammation, anxiety and other diseases | Health Technology |
Saegis Pharmaceuticals, Inc.
 Saegis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapeutics | Health Technology |
Boston Symphony Orchestra, Inc.
Boston Symphony Orchestra, Inc. Movies/EntertainmentConsumer Services Performs symphony orchestra concerts | Consumer Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Longwood Fund Management LLC
Longwood Fund Management LLC Investment ManagersFinance Longwood Fund invests in companies located in the United States. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Finance |
Verastem, Inc.
 Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of new fertility treatment options for women | Health Technology |
Longwood Fund II GP LLC | |
Commercial Club of Boston
Commercial Club of Boston Miscellaneous Commercial ServicesCommercial Services Commercial Club of Boston is a company that operates in the Membership Organizations industry. It employs 50 to 99 people and has 5M to 10M of revenue. Commercial Club of Boston is based in Boston, MA. | Commercial Services |
TScan Therapeutics, Inc.
 TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
Werewolf Therapeutics, Inc.
 Werewolf Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer | Health Technology |
Pyxis Oncology, Inc.
 Pyxis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical oncology company focused on developing an arsenal of next-generation therapeutics | Health Technology |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Health Technology |
ImmuneID, Inc.
ImmuneID, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company | Commercial Services |
DEM BioPharma, Inc.
 DEM BioPharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that manufactures cancer therapeutics | Commercial Services |
Solu Therapeutics
Solu Therapeutics BiotechnologyHealth Technology Operates as a biotechnology that develops therapeutics to eliminate disease-driving cells in cancer, immunology and autoimmunity | Health Technology |
- Stock Market
- Insiders
- Christoph Westphal
